Skip to main content
Article
Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin Level: The EUPHRATES Randomized Clinical Trial.
JAMA (2018)
  • R. Phillip Dellinger, Rowan University
  • Sean M. Bagshaw, University of Alberta
  • Massimo Antonelli, Catholic University of the Sacred Heart
  • Debra M. Foster, Spectral Medical Inc, Toronto, Canada
  • David J. Klein, University of Toronto
  • John C. Marshall, University of Toronto
  • Paul M. Palevsky, University of Pittsburgh
  • Lawrence S. Weisberg, Rowan University
  • Christa A. Schorr, Rowan University
  • Stephen Trzeciak, Rowan University
  • Paul M. Walker, Spectral Medical Inc, Toronto, Canada
Publication Date
October 9, 2018
DOI
10.1001/JAMA.2018.14618
Citation Information
R. Phillip Dellinger, Sean M. Bagshaw, Massimo Antonelli, Debra M. Foster, et al.. "Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin Level: The EUPHRATES Randomized Clinical Trial." JAMA Vol. 320 Iss. 14 (2018) p. 1455 - 1463
Available at: http://works.bepress.com/steve-trzeciak/173/